Results 121 to 130 of about 10,125,713 (289)

Plasma retinol levels in liver donors and patients with simple steatosis and non-alcoholic steatohepatitis.

, 2018
LD: liver donors, SS: simple steatosis, NASH: non-alcoholic steatohepatitis, NAFLD: non-alcoholic fatty liver disease (SS: simple steatosis + NASH: non-alcoholic steatohepatitis).
Elena M. Comelli (2802319), Ian McGilvray (5916812), Anastasia Teterina (5916809), Paulina Pettinelli (5916806), Scott K. Fung (5916815), Bianca M. Arendt (2802313), Sandra E. Fischer (2802325), Johane P. Allard (2802316)   +7 more
core   +1 more source

Metabolic Dysfunction‐Associated Steatotic Liver Disease and Obesity: Pathogenesis, Diagnostics, Risk Stratification, and Therapeutic Approach

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Metabolic dysfunction‐associated steatotic liver disease (MASLD) has emerged as the most prevalent chronic liver disease worldwide, closely linked to the global rising incidence of obesity and metabolic syndrome. This review synthesizes current evidence on the pathogenesis, gut–liver axis, and multidisciplinary management of MASLD within the ...
Beom Kyung Kim
wiley   +1 more source

Comprehensive treatment of patients with type 2 diabetes, complicated by diabetic kidney disease, with concomitant non-alcoholic steatohepatitis

Mìžnarodnij Endokrinologìčnij Žurnal
Background. The purpose of research is to establish the effect of bicyclol on the clinical manifestations of non-alcoholic steatohepatitis (NASH), markers of liver damage in patients with non-alcoholic steatohepatitis, and diabetes mellitus type 2 (DM2),
Z.Ya. Kotsiubiichuk, А.А. Antoniv, O.V. Kaushanska, L.V. Kanovska, Yu.M. Yarinich   +4 more
doaj   +1 more source

Estimated Body Fat Percentage and Triglyceride‐Glucose Index for Identifying MASLD in Lean Asian Adults: A Cross‐Sectional Analysis

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Metabolic dysfunction‐associated steatotic liver disease (MASLD) is increasingly prevalent among lean Asian populations, yet effective strategies for identifying high‐risk individuals remain limited. We investigated the associations of body fat percentage (BF%) and the triglyceride‐glucose (TyG) index with lean MASLD and evaluated their ...
Xiang‐Ran Kong, Ya‐Li Chen, Rui Li, Lu‐Xiang Shang, Sha Sha   +4 more
wiley   +1 more source

Interactive Roles of Metabolic Dysfunction‐Associated Steatotic Liver Disease and Nutritional Status in the Prognosis of Patients With Hepatocellular Carcinoma After Surgical Resection

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT The prognostic effect of concurrent metabolic dysfunction‐associated steatotic liver disease (MASLD) on outcomes for hepatocellular carcinoma (HCC) patients remains unclear. The Prognostic Nutritional Index (PNI) reflects nutritional and inflammatory status and is a well‐known prognostic factor.
Chun‐Ting Ho, Chien‐An Liu, Chia‐Jung Ho, Yi‐Chen Lin, Shin‐Yu Tsai, Hao‐Jan Lei, Shu‐Cheng Chou, Yi‐Hsiang Huang, Ming‐Chih Hou, Jaw‐Ching Wu, Chien‐Wei Su   +10 more
wiley   +1 more source

Machine learning model for non-alcoholic steatohepatitis diagnosis based on ultrasound radiomics

BMC Medical Imaging
Background Non-Alcoholic Steatohepatitis (NASH) is a crucial stage in the progression of Non-Alcoholic Fatty Liver Disease(NAFLD). The purpose of this study is to explore the clinical value of ultrasound features and radiological analysis in predicting ...
Fei Xia, Wei Wei, Junli Wang, Yayang Duan, Kun Wang, Chaoxue Zhang   +5 more
doaj   +1 more source

Exploring the Multifaceted Landscape of MASLD: A Comprehensive Synthesis of Recent Studies, from Pathophysiology to Organoids and Beyond

Biomedicines
Non-alcoholic fatty liver disease (NAFLD) is a widespread contributor to chronic liver disease globally. A recent consensus on renaming liver disease was established, and metabolic dysfunction-associated steatotic liver disease, MASLD, was chosen as the ...
Allison Soto, Colby Spongberg, Alessandro Martinino, Francesco Giovinazzo   +3 more
doaj   +1 more source

Cardiometabolic Biomarkers for Disease Severity Prediction in Metabolic Dysfunction‐Associated Steatotic Liver Disease

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT The impacts of cardiometabolic risk factors (CMRFs) and the biomarkers on disease severity in metabolic dysfunction‐associated steatotic liver disease (MASLD) remain elusive. Accordingly, a multicenter study by recruiting MASLD patients from a nationwide registry database was conducted with a total of 2882 MASLD patients (54.1% males, mean age 
Jee‐Fu Huang, Chi‐Yi Chen, Ming‐Jong Bair, Tzu‐Chun Lin, Ming‐Lun Yeh, Pei‐Chien Tsai, Yu‐Ju Wei, Chih‐Wen Wang, Po‐Chen Liang, Ming‐Yen Hsieh, Mei‐Hsuan Lee, Chia‐Yen Dai, Chung‐Feng Huang, Ming‐Lung Yu, Wan‐Long Chuang   +14 more
wiley   +1 more source

Insulin resistance in non-alcoholic steatohepatitis

, 2001
Background. Non-alcoholic steatohepatitis is a chronic liver disease that is capable of progressing to end-stage liver disease, but generally has a benign course.
Comert, B, Kocabalkan, F, Dinc, A, Unal, T, Mas, MR, Erdem, H, Kuzhan, O, Saglamkaya, U, Cigerim, M   +8 more
core   +1 more source

[Non-alcoholic steatohepatitis].

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 2001
There is a growing interest in nonalcoholic steatohepatitis (NASH), a disease entity which is quite similar to alcoholic liver disease.We present three patients with nonalcoholic steatohepatitis, and review current opinion on this disease entity.Non-alcoholic steatohepatitis is very often associated with the insulin resistance syndrome.
J W, Haukeland, Z, Konopski, H, Bell, N, Raknerud   +3 more
openaire   +3 more sources